Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis

Abstract Background Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinnosuke Komiya, Jun Watanabe, Takero Terayama, Kyosuke Kamijo, Hidetaka Okada
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Reproductive Medicine and Biology
Subjects:
Online Access:https://doi.org/10.1002/rmb2.12573
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850053104357081088
author Shinnosuke Komiya
Jun Watanabe
Takero Terayama
Kyosuke Kamijo
Hidetaka Okada
author_facet Shinnosuke Komiya
Jun Watanabe
Takero Terayama
Kyosuke Kamijo
Hidetaka Okada
author_sort Shinnosuke Komiya
collection DOAJ
description Abstract Background Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of follitropin δ and follitropin α/β. Methods We searched randomized controlled trials comparing follitropin δ and follitropin α/β using MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO‐ITCRP on December 14, 2022. The primary outcomes were the live birth rate and the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS). The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation approach. The protocol was registered on the Open Science Framework. Results Three studies involving 2682 participants were included in our meta‐analysis. The results indicated that follitropin δ may result in little to no difference in live birth rates (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.91–1.38; low certainty) and the incidence of moderate or severe OHSS (RR, 0.78; 95% CI, 0.48–1.26; low certainty) compared with follitropin α/β. Conclusion Follitropin δ may result in little to no difference in COS compared with follitropin α/β, especially in terms of live births and safety.
format Article
id doaj-art-da5bd65a19a54f5cba194122fab5a79b
institution DOAJ
issn 1445-5781
1447-0578
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Reproductive Medicine and Biology
spelling doaj-art-da5bd65a19a54f5cba194122fab5a79b2025-08-20T02:52:37ZengWileyReproductive Medicine and Biology1445-57811447-05782024-01-01231n/an/a10.1002/rmb2.12573Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysisShinnosuke Komiya0Jun Watanabe1Takero Terayama2Kyosuke Kamijo3Hidetaka Okada4HORAC Grand Front Osaka Clinic Osaka JapanSystematic Review Workshop Peer Support Group (SRWS‐PSG) Osaka JapanSystematic Review Workshop Peer Support Group (SRWS‐PSG) Osaka JapanSystematic Review Workshop Peer Support Group (SRWS‐PSG) Osaka JapanDepartment of Obstetrics and Gynecology Kansai Medical University Graduate School of Medicine Hirakata, Osaka JapanAbstract Background Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of follitropin δ and follitropin α/β. Methods We searched randomized controlled trials comparing follitropin δ and follitropin α/β using MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO‐ITCRP on December 14, 2022. The primary outcomes were the live birth rate and the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS). The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation approach. The protocol was registered on the Open Science Framework. Results Three studies involving 2682 participants were included in our meta‐analysis. The results indicated that follitropin δ may result in little to no difference in live birth rates (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.91–1.38; low certainty) and the incidence of moderate or severe OHSS (RR, 0.78; 95% CI, 0.48–1.26; low certainty) compared with follitropin α/β. Conclusion Follitropin δ may result in little to no difference in COS compared with follitropin α/β, especially in terms of live births and safety.https://doi.org/10.1002/rmb2.12573assisted reproductive techniquesfemale infertilityfertilization in vitrofollicle‐stimulating hormoneovarian hyperstimulation syndrome
spellingShingle Shinnosuke Komiya
Jun Watanabe
Takero Terayama
Kyosuke Kamijo
Hidetaka Okada
Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
Reproductive Medicine and Biology
assisted reproductive techniques
female infertility
fertilization in vitro
follicle‐stimulating hormone
ovarian hyperstimulation syndrome
title Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
title_full Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
title_fullStr Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
title_full_unstemmed Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
title_short Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
title_sort efficacy and safety of follitropin delta versus follitropin alpha beta in infertility treatment a systematic review and meta analysis
topic assisted reproductive techniques
female infertility
fertilization in vitro
follicle‐stimulating hormone
ovarian hyperstimulation syndrome
url https://doi.org/10.1002/rmb2.12573
work_keys_str_mv AT shinnosukekomiya efficacyandsafetyoffollitropindeltaversusfollitropinalphabetaininfertilitytreatmentasystematicreviewandmetaanalysis
AT junwatanabe efficacyandsafetyoffollitropindeltaversusfollitropinalphabetaininfertilitytreatmentasystematicreviewandmetaanalysis
AT takeroterayama efficacyandsafetyoffollitropindeltaversusfollitropinalphabetaininfertilitytreatmentasystematicreviewandmetaanalysis
AT kyosukekamijo efficacyandsafetyoffollitropindeltaversusfollitropinalphabetaininfertilitytreatmentasystematicreviewandmetaanalysis
AT hidetakaokada efficacyandsafetyoffollitropindeltaversusfollitropinalphabetaininfertilitytreatmentasystematicreviewandmetaanalysis